Viridian Therapeutics, Inc.\DE (VRDN) Return on Sales Growth (3y) (2016 - 2026)
Viridian Therapeutics, Inc.\DE (VRDN) Return on Sales Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -76.00 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 8.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -1.00 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 3.00 |
| 10 | Viridian Therapeutics, Inc.\DE | 2.50 Bn | 2.50 Bn | - | 199.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 199.00 |
| Mar 31, 2026 | -97.00 |
| Dec 31, 2025 | -318.00 |
| Sep 30, 2025 | 24.00 |
| Jun 30, 2025 | -1,374.00 |
| Mar 31, 2025 | -1,189.00 |
| Dec 31, 2024 | -962.00 |
| Sep 30, 2024 | -996.00 |
| Jun 30, 2024 | -997.00 |
| Mar 31, 2024 | -788.00 |
| Dec 31, 2023 | 514.00 |
| Sep 30, 2023 | -650.00 |
| Jun 30, 2023 | -723.00 |
| Mar 31, 2023 | -685.00 |
| Dec 31, 2022 | -429.00 |
| Sep 30, 2022 | -15.00 |
| Jun 30, 2022 | -113.00 |
| Mar 31, 2022 | -87.00 |
| Dec 31, 2021 | -114.00 |
| Sep 30, 2021 | -58.00 |